Related Experiment Video

Updated: May 13, 2026

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
04:00

A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells

Published on: September 7, 2011

66.0K

Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies

Xueru Liu1, Juan Zhang1, Ting Yi2

  • 1Department of Assisted Reproductive Centre, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412000, Hunan, China.

Biomarker Research
|April 18, 2025
PubMed

Insights

This review explores anti-angiogenesis strategies for cancer, focusing on molecular mechanisms and therapeutic targets. It highlights challenges like drug resistance and discusses future directions for anti-angiogenic therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Angiogenesis is vital for tumor growth and metastasis.
  • Targeted anti-angiogenesis therapies are crucial for cancer treatment.
  • Understanding tumor microenvironment and endothelial cell metabolism is key.

Purpose of the Study:

  • To review the latest knowledge on anti-angiogenesis targets in tumors.
  • To analyze molecular mechanisms and signaling pathways regulating tumor angiogenesis.
  • To evaluate therapeutic strategies and future trends in anti-angiogenesis drug development.

Main Methods:

  • Comprehensive literature review of anti-angiogenesis research.
  • Analysis of molecular mechanisms and signaling pathways.
  • Evaluation of therapeutic strategies and drug development trends.

Main Results:

  • Detailed analysis of signaling pathways and molecular mechanisms of tumor angiogenesis.
  • Identification of key molecular targets within the tumor microenvironment.
  • Assessment of current and emerging therapeutic strategies targeting tumor vasculature.

Conclusions:

  • Anti-angiogenic therapies show promise but face challenges like drug resistance and side effects.
  • Ongoing research is needed to improve cancer treatment strategies and therapeutic efficacy.
  • Future directions include developing novel drugs and overcoming treatment resistance.
Keywords:
Anti-angiogenic therapyCancerEndothelialMolecular PathwaysTumor AngiogenesisTumor microenvironmentVascular targeting

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

9.7K
Isolation and Culture Expansion of Tumor-specific Endothelial Cells10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

11.1K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.